Literature DB >> 11211639

Smoking during pregnancy in Finland: determinants and trends, 1987-1997.

N Jaakkola1, M S Jaakkola, M Gissler, J J Jaakkola.   

Abstract

OBJECTIVES: This study examined determinants of and trends in smoking during pregnancy in Finland from 1987 through 1997.
METHODS: A repeated cross-sectional investigation of 694,926 women was conducted.
RESULTS: The prevalence of smoking during pregnancy remained similar from 1987 through 1997 (at 15%). In 1997, prevalences of smoking were alarmingly high among young (37%), single (30%), and less educated (25%) women and among women living in northern (20%) and eastern (19%) Finland. These determinants were persistent over time, with the exception of an increase in regional differences.
CONCLUSIONS: Despite increasing knowledge of adverse effects, smoking during pregnancy has not declined in Finland over the past decade.

Entities:  

Mesh:

Year:  2001        PMID: 11211639      PMCID: PMC1446524          DOI: 10.2105/ajph.91.2.284

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  2 in total

1.  Trends in smoking during pregnancy in England, 1992-7: quota sampling surveys.

Authors:  L Owen; A McNeill; C Callum
Journal:  BMJ       Date:  1998-09-12

Review 2.  Determinants of low birth weight: methodological assessment and meta-analysis.

Authors:  M S Kramer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  2 in total
  27 in total

1.  Prenatal health, educational attainment, and intergenerational inequality: the Northern Finland Birth Cohort 1966 Study.

Authors:  Juho Härkönen; Hande Kaymakçalan; Pirjo Mäki; Anja Taanila
Journal:  Demography       Date:  2012-05

2.  Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta.

Authors:  Matthew A Maccani; Michele Avissar-Whiting; Carolyn E Banister; Bethany McGonnigal; James F Padbury; Carmen J Marsit
Journal:  Epigenetics       Date:  2010-10-01       Impact factor: 4.528

3.  Parker et al. Respond to "Preeclampsia Risk After Induced Abortion".

Authors:  Samantha E Parker; Mika Gissler; Cande V Ananth; Martha M Werler
Journal:  Am J Epidemiol       Date:  2015-09-15       Impact factor: 4.897

4.  Changes in maternal characteristics in Nova Scotia, Canada from 1988 to 2001.

Authors:  Deshayne B Fell; K S Joseph; Linda Dodds; Alexander C Allen; Krista Jangaard; Michiel Van den Hof
Journal:  Can J Public Health       Date:  2005 May-Jun

5.  Prevalence and predictors of smoking and quitting during pregnancy in Serbia: results of a nationally representative survey.

Authors:  Srmena Krstev; Jelena Marinković; Snežana Simić; Nikola Kocev; Susan J Bondy
Journal:  Int J Public Health       Date:  2011-09-16       Impact factor: 3.380

6.  Spiritual Health and Physical Activity Among Iranian Pregnant Women.

Authors:  Soheila Rabiepoor; Elham Sadeghi; Hojjat Sayyadi
Journal:  J Relig Health       Date:  2019-04

7.  ENHANCING THE EFFECTIVENESS OF RESIDENTIAL TREATMENT FOR SUBSTANCE ABUSING PREGNANT AND PARENTING WOMEN: FOCUS ON MATERNAL REFLECTIVE FUNCTIONING AND MOTHER-CHILD RELATIONSHIP.

Authors:  Marjukka Pajulo; Nancy Suchman; Mirjam Kalland; Linda Mayes
Journal:  Infant Ment Health J       Date:  2006-09-01

Review 8.  The epigenetics of maternal cigarette smoking during pregnancy and effects on child development.

Authors:  Valerie S Knopik; Matthew A Maccani; Sarah Francazio; John E McGeary
Journal:  Dev Psychopathol       Date:  2012-11

9.  Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland.

Authors:  Miia Artama; Mika Gissler; Heli Malm; Annukka Ritvanen
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

10.  Register based monitoring shows decreasing socioeconomic differences in Finnish perinatal health.

Authors:  M Gissler; J Meriläinen; E Vuori; E Hemminki
Journal:  J Epidemiol Community Health       Date:  2003-06       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.